The Wolverine Stack for dogs combines two of the most extensively studied regenerative peptides, BPC-157 and TB-500, into a synergistic protocol designed for comprehensive tissue repair research. Named for its association with enhanced recovery, this peptide combination has become the most popular multi-peptide approach in veterinary research circles.

This guide covers the scientific rationale behind combining BPC-157 and TB-500 for canine applications, provides complete weight-based dosing tables, walks through reconstitution and administration procedures, and explains how to design effective veterinary research protocols using this dual-peptide approach.

What Is the Wolverine Stack for Dogs and Why Combine Two Peptides?

The Wolverine Stack pairs BPC-157 (Body Protection Compound-157) with TB-500 (a synthetic fragment of Thymosin Beta-4) based on the principle that their complementary mechanisms produce outcomes superior to either peptide alone. Each peptide addresses different aspects of the tissue repair cascade, creating a more complete regenerative response when administered together.

BPC-157’s Contribution to the Stack

BPC-157 brings tissue protection, growth factor upregulation, and nitric oxide system modulation to the combination. Research documented in the published BPC-157 research confirms BPC-157 promotes VEGF (vascular endothelial growth factor), EGF receptor activation, and nerve growth factor expression. Additionally, BPC-157 provides gastroprotective effects that counteract NSAID-induced GI damage, a significant advantage for dogs on concurrent pain medication. The BPC-157 research guide details these mechanisms comprehensively.

TB-500’s Contribution to the Stack

TB-500 contributes actin regulation for enhanced cell migration, potent angiogenesis (new blood vessel formation), and strong anti-inflammatory cytokine modulation. Research published in the published thymosin beta-4 research confirms Thymosin Beta-4’s role in promoting cell migration and tissue repair. Its ability to mobilize stem cells and progenitor cells toward injury sites adds a regenerative dimension that BPC-157 alone does not fully provide. The TB-500 research guide covers Thymosin Beta-4’s unique mechanism in detail.

Synergistic Mechanisms

When combined, the two peptides address the tissue repair cascade from multiple angles simultaneously. The synergistic rationale operates as follows:

This multi-pathway approach is why the Wolverine Stack has generated such significant interest in veterinary research. The detailed comparison of both peptides is available in the BPC-157 vs TB-500 comparison guide.

How Do You Dose the Wolverine Stack for Dogs by Weight?

The Wolverine Stack uses established dosing ranges for each peptide, administered concurrently. BPC-157 is dosed daily while TB-500 follows a loading-and-maintenance schedule. The following tables provide weight-based protocols for all standard canine size categories.

BPC-157 Component (Daily Administration)

TB-500 Component (Loading + Maintenance)

Precision in dosing is critical for both components. The PSPeptides peptide calculator handles the math for both peptides, converting between concentrations and syringe volumes for any reconstitution ratio. For a deeper look at the dosing principles, see the BPC-157 dosage guide.

How Do You Reconstitute the Wolverine Stack for Dogs?

Reconstitution technique affects the accuracy of every dose in your research protocol. Whether using individual BPC-157 and TB-500 vials or the pre-blended combination product, proper reconstitution is non-negotiable for reliable research outcomes.

Option 1: Individual Vials (BPC-157 + TB-500 Separately)

When using separate vials, each peptide is reconstituted independently with bacteriostatic water. This approach gives researchers full control over the concentration and dosing of each peptide independently.

BPC-157 reconstitution: Add 2 mL of bacteriostatic water to a 5 mg vial, creating a concentration of 2500 mcg/mL. For a 25 kg dog at 10 mcg/kg (250 mcg dose), draw 0.10 mL (10 units on a standard insulin syringe).

TB-500 reconstitution: Add 2 mL of bacteriostatic water to a 5 mg vial, creating a concentration of 2500 mcg/mL. For a 25 kg dog in loading phase (2.5 mg dose), draw 1.0 mL. Some researchers prefer to reconstitute TB-500 at higher concentrations (5 mg/mL) to reduce injection volumes.

Both injections can be administered at the same time or at different times of day. They should not be mixed in the same syringe unless using the pre-blended product. Detailed reconstitution instructions are available in the peptide reconstitution guide.

Option 2: Pre-Blended BPC-157 + TB-500

The BPC-157 + TB-500 blend from PSPeptides combines both peptides in a single vial, eliminating the need for separate reconstitution and reducing handling steps. This option is particularly practical for veterinary research settings where simplicity reduces error risk.

The blend is reconstituted once with bacteriostatic water, and each injection delivers both peptides in the pre-determined ratio. This format is ideal for researchers running standard combination protocols without the need for independent dose adjustment of each component.

What Conditions in Dogs Benefit from Wolverine Stack Research?

The dual-mechanism approach of the Wolverine Stack makes it particularly suited for conditions where multiple healing pathways need simultaneous support. The following canine conditions represent the most promising research targets.

Cruciate Ligament Injuries

Cranial cruciate ligament (CCL) rupture is the single most common orthopedic condition requiring surgery in dogs, as documented in research available through the Journal of Orthopaedic Research. Post-surgical recovery involves healing of the repaired or replaced ligament, resolution of joint inflammation, and restoration of surrounding muscle strength. The Wolverine Stack addresses inflammation (both peptides), tissue repair (BPC-157’s collagen organization), cell recruitment (TB-500’s migration effects), and vascularization (TB-500’s angiogenesis).

For dogs managed conservatively (without surgery), the stack’s comprehensive tissue support may help stabilize partially torn ligaments and reduce the chronic inflammation that drives progressive joint damage. Research on peptide applications for joint conditions is covered in the peptides for joint and tendon repair resource.

Multi-Tissue Injuries

Traumatic injuries from car accidents, falls, or athletic activity often involve damage to multiple tissue types simultaneously: skin, muscle, tendon, ligament, and sometimes nerve. The Wolverine Stack’s broad regenerative spectrum addresses these multi-tissue injuries more comprehensively than a single-peptide approach. BPC-157’s nerve growth factor upregulation and TB-500’s cell migration effects collectively support repair across tissue types.

Age-Related Degeneration

Senior dogs frequently present with multiple concurrent degenerative conditions: osteoarthritis, tendinopathy, reduced wound healing capacity, and chronic low-grade inflammation. The Wolverine Stack’s anti-inflammatory and regenerative mechanisms may address the systemic tissue decline associated with aging, providing a research framework for geriatric canine wellness. The peptides for senior dogs page provides additional context for age-related applications.

How Do You Design a Wolverine Stack Research Protocol for Dogs?

Effective protocol design ensures reproducible results and maximizes the value of each research dollar invested. The following framework addresses the key elements of a well-designed Wolverine Stack study.

Phase 1: Preparation (Days 1-3)

Obtain baseline measurements including body weight, condition scoring, lameness evaluation, and diagnostic imaging of the target condition. Reconstitute all peptides and confirm concentrations via the peptide calculator. Verify all supplies are on hand, including sufficient bacteriostatic water, insulin syringes, and alcohol swabs for the full protocol duration.

Phase 2: Loading (Weeks 1-4)

Administer BPC-157 daily (SubQ, 10 mcg/kg) and TB-500 twice weekly (SubQ, 0.1 mg/kg). The loading phase establishes therapeutic tissue concentrations of both peptides. Assessment at the end of week 2 and week 4 provides early response data. Adjust dosing only if pre-specified protocol criteria for dose modification are met.

Phase 3: Maintenance (Weeks 5-12)

Continue BPC-157 daily at the same dose. Reduce TB-500 to once weekly at half the loading dose. This phase sustains the regenerative stimulus while reducing peptide consumption and injection frequency. Monthly assessments track progress and identify any emerging concerns.

Phase 4: Assessment (Week 12+)

Comprehensive final assessment including repeat imaging, functional evaluation, and comparison with baseline measurements. Verify that the peptide quality was maintained throughout the protocol by checking the certificate of analysis documentation for each batch used.

Where to Buy the Wolverine Stack for Dogs Research

Sourcing both peptides from a single, quality-verified supplier simplifies procurement and ensures batch consistency throughout your research protocol. PSPeptides provides every component needed for Wolverine Stack veterinary research.

Complete your Wolverine Stack research kit:

• BPC-157 + TB-500 Blend for simplified single-vial protocols, or purchase BPC-157 and TB-500 separately for independent dose control
• Bacteriostatic Water for reconstitution
• Insulin Syringes for precise veterinary dosing
• Third-party COA with every batch confirming greater than 98% purity via HPLC
• Same-day shipping to keep your protocol on schedule
• Flexible payment with Afterpay, Klarna, and all major credit cards
• Free peptide calculator for weight-based dosing of both peptides

Visit the PSPeptides shop to build your complete research supply order in one transaction.

Frequently Asked Questions About the Wolverine Stack for Dogs

Is the Wolverine Stack better than using BPC-157 or TB-500 alone for dogs?

The combination approach addresses more healing pathways simultaneously than either peptide alone. BPC-157 and TB-500 operate through complementary mechanisms: BPC-157 focuses on tissue protection and growth factor modulation while TB-500 drives cell migration and angiogenesis. For complex or multi-tissue injuries, the combination provides more comprehensive support. For simple, localized conditions, a single peptide may be sufficient.

Can you mix BPC-157 and TB-500 in the same syringe?

When using individually reconstituted peptides from separate vials, it is generally recommended to administer them as separate injections to ensure accurate dosing of each component. However, the pre-blended BPC-157 + TB-500 product from PSPeptides is specifically formulated for single-vial delivery, ensuring proper ratios and compatibility in a single injection.

How long should a Wolverine Stack protocol last for dogs?

Standard protocols run 8-12 weeks, with a 4-week loading phase followed by a 4-8 week maintenance phase. Acute injuries may respond adequately with shorter protocols (6-8 weeks), while chronic degenerative conditions like osteoarthritis may benefit from extended maintenance periods of 12 weeks or longer. Protocol duration should be determined by the specific research question and condition type.

What signs of improvement should researchers monitor during a Wolverine Stack protocol?

Key monitoring parameters include changes in lameness grade, weight-bearing patterns (ideally via force plate analysis), range of motion in affected joints, ultrasonographic changes in soft tissue injuries, owner-reported activity levels and comfort scores, and any adverse reactions at injection sites. Systematic documentation at regular intervals provides the data needed for meaningful analysis.

All PSPeptides products are sold exclusively for research and laboratory use.